SARS-CoV-2 variants inactivation of plasma units using a riboflavin and ultraviolet light-based photochemical treatment

BACKGROUND: Test the ability of Mirasol Pathogen Reduction Technology (PRT, Terumo BCT, Lakewood Co, USA) treatment with riboflavin and ultraviolet light (R + UV) in reducing SARS-CoV-2 infectivity while maintaining blood product quality. MATERIAL AND METHODS: SARS-CoV-2 strains were isolated and ti...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrari, Alessandro, Cassaniti, Irene, Sammartino, Josè Camilla, Mortellaro, Cristina, Del Fante, Claudia, De Vitis, Simona, Barone, Eugenio, Troletti, Daniela, Prati, Federica, Baldanti, Fausto, Percivalle, Elena, Cesare, Perotti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847076/
https://www.ncbi.nlm.nih.gov/pubmed/35227599
http://dx.doi.org/10.1016/j.transci.2022.103398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847076/
https://www.ncbi.nlm.nih.gov/pubmed/35227599
http://dx.doi.org/10.1016/j.transci.2022.103398

Ejemplares similares